Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ qE=OQs9
1yc@q8
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© =LA@E&,j
S3wH
M
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© fdW={}~
o)WSMV(&f
1.Co-stimulators (or co-stimulating molecules) o|C{ s
~cw
wB{
2.NK-kB _"`h~jB
Ry3 f'gx
3.Immunoglobulin superfamily *h9vMks
o
OSk9Eb4ld
4.antigen-presenting cell (APC) {*Pp^r
N4-J !r@#~
5.death domain #m>mYp8E.5
7i
/Cax
6.CCR and CXCR YZ@-0_Z
2O/_hv.
7.Lectin (or mitogen) *Cw2 h
[DwB7l)O(
8.Clusters of differentiation, CD) ^EOjq
566Qikw2
9.B7 family ri
~2t3gg
/
jD'o>
10.Cytotoxic T lymphocyte, CTL) mZyTo/\0
q0wVV
11.IL-15 and IL-15 receptor (IL-15R) 6tg
uy
-}@9lhS,
12.MHC restriction Rd)QVEk>SD
O [/~V=
13.Affinity-chromatography %L3]l
uc_
X;M;
14.Cyctosprin A, CsA pC6_
jIZ
OjZ@_V:
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) EeO{G*pq
I1gu<a
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 0NxaQ`\
scdT/|(U$
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 #_d%hr~d
+-hmITJv
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ~J|0G6H
7u zN/LAF
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ L" o6)N
)Ii=8etdv
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© X\;y;pmRH
mWh:,[o
ÃâÒßѧרҵ£º 5GKz@as8
}^H_|;e1p
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ qVfOf\x.e
/vu7;xVG
Ïû»¯ÄÚ¿Æ£º rZLMYM
>_@J&vC
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
:z[SI{Y
=6Z1yw7s
ѪҺ²¡Ñ§×¨Òµ£º m\(a{x
ek9%Xk8
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿